Tube Investments of India Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 29, 2025, 10:52 pm

Quick Insight

Tube Investments of India Ltd, with a share price of ₹3,312 and a market capitalization of ₹64,094 Cr., exhibits a high Price-to-Earnings ratio of 99.1, reflecting potentially rich valuations compared to sector averages in India. However, the company boasts a respectable Return on Equity (ROE) of 12.8% and Return on Capital Employed (ROCE) of 21.8%, indicating efficient utilization of capital. With a healthy Operating Profit Margin (OPM) of 10% and a strong Interest Coverage Ratio (ICR) of 34.99x, Tube Investments demonstrates operational stability and financial strength.

Despite these strengths, the company faces risks due to its high P/E ratio, suggesting investor expectations may be lofty. Additionally, with significant borrowings amounting to ₹703 Cr., there could be increased financial leverage risk, especially given the Current Credit Cycle (CCC) of 36 days. Looking forward, Tube Investments could improve its outlook by focusing on reducing its borrowing levels, enhancing operational efficiencies to further boost ROE and ROCE, and diversifying its shareholder base beyond the current concentration among promoters, FIIs, and DIIs.

In conclusion, while Tube Investments of India Ltd shows promise with strong operational metrics, investors should carefully monitor its valuation multiples and debt levels to mitigate risks and capitalize on potential growth opportunities in the dynamic cycles and accessories industry.

Competitors of Tube Investments of India Ltd

All Competitor Stocks of Tube Investments of India Ltd

Quarterly Result

Last Updated: August 20, 2025, 2:00 am

Below is a detailed analysis of the quarterly data for Tube Investments of India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 5,309.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,150.00 Cr. (Mar 2025) to 5,309.00 Cr., marking an increase of 159.00 Cr..
• For Expenses, as of Jun 2025, the value is 4,763.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4,813.00 Cr. (Mar 2025) to 4,763.00 Cr., marking a decrease of 50.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 546.00 Cr.. The value appears strong and on an upward trend. It has increased from 337.00 Cr. (Mar 2025) to 546.00 Cr., marking an increase of 209.00 Cr..
• For OPM %, as of Jun 2025, the value is 10.00%. The value appears strong and on an upward trend. It has increased from 7.00% (Mar 2025) to 10.00%, marking an increase of 3.00%.
• For Other Income, as of Jun 2025, the value is 72.00 Cr.. The value appears to be declining and may need further review. It has decreased from 150.00 Cr. (Mar 2025) to 72.00 Cr., marking a decrease of 78.00 Cr..
• For Interest, as of Jun 2025, the value is 17.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 16.00 Cr. (Mar 2025) to 17.00 Cr., marking an increase of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 152.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 137.00 Cr. (Mar 2025) to 152.00 Cr., marking an increase of 15.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 449.00 Cr.. The value appears strong and on an upward trend. It has increased from 334.00 Cr. (Mar 2025) to 449.00 Cr., marking an increase of 115.00 Cr..
• For Tax %, as of Jun 2025, the value is 32.00%. The value appears to be improving (decreasing) as expected. It has decreased from 53.00% (Mar 2025) to 32.00%, marking a decrease of 21.00%.
• For Net Profit, as of Jun 2025, the value is 303.00 Cr.. The value appears strong and on an upward trend. It has increased from 158.00 Cr. (Mar 2025) to 303.00 Cr., marking an increase of 145.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 10.28. The value appears strong and on an upward trend. It has increased from 2.40 (Mar 2025) to 10.28, marking an increase of 7.88.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:49 pm

Growth

Last Updated: September 5, 2025, 1:50 pm

Balance Sheet

Last Updated: July 25, 2025, 2:10 pm

Below is a detailed analysis of the balance sheet data for Tube Investments of India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 19.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 19.00 Cr..
• For Reserves, as of Mar 2025, the value is 5,516.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,086.00 Cr. (Mar 2024) to 5,516.00 Cr., marking an increase of 430.00 Cr..
• For Borrowings, as of Mar 2025, the value is 703.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 896.00 Cr. (Mar 2024) to 703.00 Cr., marking a decrease of 193.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 9,640.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7,082.00 Cr. (Mar 2024) to 9,640.00 Cr., marking an increase of 2,558.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 15,879.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13,084.00 Cr. (Mar 2024) to 15,879.00 Cr., marking an increase of 2,795.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 5,210.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,393.00 Cr. (Mar 2024) to 5,210.00 Cr., marking an increase of 817.00 Cr..
• For CWIP, as of Mar 2025, the value is 770.00 Cr.. The value appears strong and on an upward trend. It has increased from 381.00 Cr. (Mar 2024) to 770.00 Cr., marking an increase of 389.00 Cr..
• For Investments, as of Mar 2025, the value is 931.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,370.00 Cr. (Mar 2024) to 931.00 Cr., marking a decrease of 439.00 Cr..
• For Other Assets, as of Mar 2025, the value is 8,969.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,940.00 Cr. (Mar 2024) to 8,969.00 Cr., marking an increase of 2,029.00 Cr..
• For Total Assets, as of Mar 2025, the value is 15,879.00 Cr.. The value appears strong and on an upward trend. It has increased from 13,084.00 Cr. (Mar 2024) to 15,879.00 Cr., marking an increase of 2,795.00 Cr..

Notably, the Reserves (5,516.00 Cr.) exceed the Borrowings (703.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Tube Investments of India Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 34.83. This value is within the healthy range. It has decreased from 62.12 (Mar 24) to 34.83, marking a decrease of 27.29.
• For Diluted EPS (Rs.), as of Mar 25, the value is 34.80. This value is within the healthy range. It has decreased from 62.04 (Mar 24) to 34.80, marking a decrease of 27.24.
• For Cash EPS (Rs.), as of Mar 25, the value is 79.94. This value is within the healthy range. It has decreased from 113.17 (Mar 24) to 79.94, marking a decrease of 33.23.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 286.08. It has decreased from 348.74 (Mar 24) to 286.08, marking a decrease of 62.66.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 286.08. It has decreased from 348.74 (Mar 24) to 286.08, marking a decrease of 62.66.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,005.93. It has increased from 873.34 (Mar 24) to 1,005.93, marking an increase of 132.59.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 114.74. This value is within the healthy range. It has increased from 113.81 (Mar 24) to 114.74, marking an increase of 0.93.
• For PBIT / Share (Rs.), as of Mar 25, the value is 89.31. This value is within the healthy range. It has decreased from 89.74 (Mar 24) to 89.31, marking a decrease of 0.43.
• For PBT / Share (Rs.), as of Mar 25, the value is 85.46. This value is within the healthy range. It has decreased from 87.05 (Mar 24) to 85.46, marking a decrease of 1.59.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 54.50. This value is within the healthy range. It has decreased from 89.10 (Mar 24) to 54.50, marking a decrease of 34.60.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 34.82. This value is within the healthy range. It has decreased from 62.08 (Mar 24) to 34.82, marking a decrease of 27.26.
• For PBDIT Margin (%), as of Mar 25, the value is 11.40. This value is within the healthy range. It has decreased from 13.03 (Mar 24) to 11.40, marking a decrease of 1.63.
• For PBIT Margin (%), as of Mar 25, the value is 8.87. This value is below the healthy minimum of 10. It has decreased from 10.27 (Mar 24) to 8.87, marking a decrease of 1.40.
• For PBT Margin (%), as of Mar 25, the value is 8.49. This value is below the healthy minimum of 10. It has decreased from 9.96 (Mar 24) to 8.49, marking a decrease of 1.47.
• For Net Profit Margin (%), as of Mar 25, the value is 5.41. This value is within the healthy range. It has decreased from 10.20 (Mar 24) to 5.41, marking a decrease of 4.79.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.46. This value is below the healthy minimum of 8. It has decreased from 7.10 (Mar 24) to 3.46, marking a decrease of 3.64.
• For Return on Networth / Equity (%), as of Mar 25, the value is 12.17. This value is below the healthy minimum of 15. It has decreased from 23.54 (Mar 24) to 12.17, marking a decrease of 11.37.
• For Return on Capital Employeed (%), as of Mar 25, the value is 16.10. This value is within the healthy range. It has decreased from 20.94 (Mar 24) to 16.10, marking a decrease of 4.84.
• For Return On Assets (%), as of Mar 25, the value is 4.22. This value is below the healthy minimum of 5. It has decreased from 9.11 (Mar 24) to 4.22, marking a decrease of 4.89.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.08. This value is within the healthy range. It has decreased from 0.14 (Mar 24) to 0.08, marking a decrease of 0.06.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.34. It has decreased from 1.44 (Mar 24) to 1.34, marking a decrease of 0.10.
• For Current Ratio (X), as of Mar 25, the value is 1.80. This value is within the healthy range. It has increased from 1.62 (Mar 24) to 1.80, marking an increase of 0.18.
• For Quick Ratio (X), as of Mar 25, the value is 1.38. This value is within the healthy range. It has increased from 1.25 (Mar 24) to 1.38, marking an increase of 0.13.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.00. This value is within the healthy range. It has decreased from 6.66 (Mar 24) to 6.00, marking a decrease of 0.66.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 5.63 (Mar 24) to 0.00, marking a decrease of 5.63.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 4.06 (Mar 24) to 0.00, marking a decrease of 4.06.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 94.37 (Mar 24) to 0.00, marking a decrease of 94.37.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 95.94 (Mar 24) to 0.00, marking a decrease of 95.94.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 34.99. This value is within the healthy range. It has decreased from 42.12 (Mar 24) to 34.99, marking a decrease of 7.13.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 17.79. This value is within the healthy range. It has decreased from 23.72 (Mar 24) to 17.79, marking a decrease of 5.93.
• For Enterprise Value (Cr.), as of Mar 25, the value is 54,178.27. It has decreased from 73,321.11 (Mar 24) to 54,178.27, marking a decrease of 19,142.84.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.78. This value is within the healthy range. It has decreased from 4.34 (Mar 24) to 2.78, marking a decrease of 1.56.
• For EV / EBITDA (X), as of Mar 25, the value is 24.40. This value exceeds the healthy maximum of 15. It has decreased from 33.31 (Mar 24) to 24.40, marking a decrease of 8.91.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.75. This value is within the healthy range. It has decreased from 4.27 (Mar 24) to 2.75, marking a decrease of 1.52.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 94.36 (Mar 24) to 0.00, marking a decrease of 94.36.
• For Price / BV (X), as of Mar 25, the value is 9.69. This value exceeds the healthy maximum of 3. It has decreased from 14.15 (Mar 24) to 9.69, marking a decrease of 4.46.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.75. This value is within the healthy range. It has decreased from 4.27 (Mar 24) to 2.75, marking a decrease of 1.52.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness